Breast cancer AI firm Volpara sees strong cash receipts

Breast cancer AI firm Volpara sees strong cash receipts
Rebecca Howard
ASX-listed Volpara Health Technologies collected its highest quarterly cash receipts since listing in 2016. Wellington-based Volpara, which focuses on early detection of breast cancer using artificial intelligence, said it received nearly $5.0 million in the first quarter to June 20, up 112 percent on the year.  It was the fourth straight quarter with cash receipts over $4.5 million. “Q1 saw the emergence of covid-19, but we’re very heartened by the strong cash receipts, negligible churn, and the fact that we got a significant number of n...

More Services

Aussie fund manager Shaws buys Devon Funds
Finance

Aussie fund manager Shaws buys Devon Funds

The deal is the latest tie-up between Australian and NZ funds managers.

Staff reporters 24 Jun 2025
Buy NZ Made's new service trademark sets high bar
Services

Buy NZ Made's new service trademark sets high bar

One certified business says it sets it apart from multinational competitors.

John Anthony 23 Jun 2025
Reel pain: Strikes hit NZ cinemas, profits dive
Services

Reel pain: Strikes hit NZ cinemas, profits dive

Cinema chains in NZ face box office suspense.

Victoria Young 28 May 2025
PEP seeking payday from UP Education
Finance

PEP seeking payday from UP Education

UP Education is a NZ success story in Australia.

Pattrick Smellie 23 Apr 2025